January 18, 2010
Dr. Dunker has been named as the second President of the non-profit academic society

T. K. Li Distinguished Professor Dr. A. Keith Dunker has been named as the President and Chief Executive Officer of the non-profit academic society after President Borodovsky successfully organized the society's annual meeting IJCBS in 2009. Dr. Dunker is the founder of the Protein Trinity and Protein Disorder Concept and is the currently Director of Indiana University Medical School Center for Computational Biology and Bioinformatics and Director of Bioinformatics Programs of Indiana University Purdue University Indianapolis School of Informatics. The new President, Vice-Presidents and Secretary-General resume the responsibilities for operating the non-profit academic society until the next election of the board of directors.

October 30, 2009.
PubMed, Medline, DBLP and major database inclusions of the society's academic journal.

To ensure the scientific rigor and the highest-level quality of official academic journals, the academic society selects our editors, including Editor-in-Chief, and Editorial Members, from among the world’s leading experts based on the following criteria:
• Demonstrated scientific leadership and innovation in developing and implementing scientific, medical or engineering practices that achieve significant impact on global science and technology advancement.
• Demonstrated independence and originality in his/her own research works that significantly impact on global science and technology advancement.
• Demonstrated extraordinary intellectual merit, as it impacts all aspects of the scope of peer-reviewed journal.
• Demonstrated significant contributions to the field of his/her expertise.
• Demonstrated extensive knowledge, expertise and skills in inter/multi-disciplinary scientific, medical or engineering practice fields relating to broader aims and scopes of peer-review journal.
• Demonstrated extraordinary ability and expert experience in evaluating and judging all aspects of scholarly works within the scope of peer-reviewed journal.
• Demonstrated high professionalism, consistency, and unbiased judgment on all papers submitted to peer-reviewed journal.
• One highest qualified individual is select for Editor-in-Chief of the journal, a number of highly qualified individuals are selected for Consulting Editors, Deputy Editors and Editorial Board Members
We are pleased to announce that ISIBM Fellow Dr. Mary Qu Yang of the United States National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services was selected as Editor-in-Chief of the International Journal of Computational Biology and Drug Design (IJCBDD) in 2007 and has been serving in this capacity to date. Computational biology and drug design are interactive, fast developing, synergistic fields that are impacting on the advancement of translational medicine and improvement of human health. The journal is the first peer-reviewed journal in the field. Dr. Yang is an internationally recognized scientific leader and outstanding researcher in the field, she and the editorial board have made significant contributions to promote the emerging fields. The journal is fully indexed at PubMed, Medline, DBLP and other major databases, and has achieved a leading international reputation.

October 30, 2009.
The society's annual conference in 2009.

Dr. Renzena Bajcsy, Member of United States National Academy of Sciences, Institute of Medicine, Member of United States National Academy of Engineering, and Professor of University of California at Berkeley; Dr. Michael S. Waterman, Member of United State National Academy of Sciences, Fellow of American Academy of Arts and Sciences, Academician of French Académie des Sciences and University Professor of University of Southern California; and Dr. Joydeep Ghosh, Schlumberger Centennial Chair Professor of University of Texas at Austin served as Honorary General Chairs and Steering Committee Members of IJCBS 2009, the official annual conference of the non-profit academic society. The conference received great success and attracted hundreds of scientists and researchers world-wide. The proceedings of the conference are indexed at EI, Inspec, IEEE Xplore and other databases. Drs. Joe Zhang, Guo-zheng Li and Jack Y. Yang served as Co-Editors of the IEEE proceedings book. Selected papers are also published at the society's affiliated journal issues such as the International Journal of Computational Biology and Drug Design (IJCBDD), BMC Systems Biology, BMC Genomics, and International Journal of Functional Informatics and Personalized Medicine (IJFIPM). Drs. Mingyu You, Guo-zheng Li and Mary Yang served as

Co-Editors of IJFIPM V2N3 and Drs. Ada Chen, Nazeih Botros and Mary Yang served as Co-Editors of IJFIPM V2N4. The conference is also supported by United States National Science Foundation (PI: Mary Qu Yang).


Dr. Jack Y. Yang has been elected as Chair of the Board of Directors by ISIBM Fellows (October 15th, 2007).
The "Fellow" grade of ISIBM membership is conferred by the ISIBM Board of Directors upon recommendation by the Fellow Promotion Committee after a strict nomination and approval process, based upon an individual's outstanding contributions to the field of intelligent biology and medicine. Selection to the position of an ISIBM Fellow by his/her peer professionals worldwide signifies recognition of a member's outstanding achievements in the field, and his/her proven record of accomplishments.

Every 6 years, Fellows elect the Board of Directors and a chairperson of Board of Directors. The Board of Directors names the society's president who is chief executive officer of the academic society.

ISIBM Fellow Dr. Jack Y. Yang of Harvard University in Cambridge has been elected by Fellows of ISIBM on October 15th 2007 to be the Chair of the Board of Directors of the academic society. Effective immediately Dr. Yang will coordinate the board of directors until the next election in 2013. "We are excited about the expertise and solid reputation of Dr. Yang who is a nationally and internationally well known specialist in the field", said Dr. Hamid R. Arabnia, Executive Vice-President of the society and a Professor of University of Georgia, Dr. Yang is famous for his initiatives and seminal research in integrating intelligent computing with genomics to solve significant personalized medical problems. His expertise and wisdom will be a valuable asset to the society".

The Board of Directors then named Dr. Mark Borodovksy as the president and chief executive officer of the society. Dr. Borodovsky is the creator of the GeneMark program, and founder of the Georgia Institute of Technology Bioinformatics Ph.D. Program. He is a Distinguished Regents' Professor and Director of Center for Bioinformatics and Computational Genomics at Georgia Tech. The president and Vice-Presidents are responsible for operating the non-profit academic society.



Copyright © 2007 - 2010 International Society of Intelligent Biological Medicine. All rights reserved.